It is a pharma private limited company based in Shaikpet, Telangana, India, established in 2022.
2022 | Shaikpet, Telangana, India | ActiveOrizo Pharma Private Limited, a active private limited company, was established on 06 January 2022 in Shaikpet, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290TG2022PTC158573. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.70 Cr and a paid-up capital of ₹1.70 Cr.
Its leadership includes Zubin Keki Gandhi (Director), Yatin Kirtanlal Desai (Director), Punit Chunilal Thakrar (Director). Past directors included Raghu Rayala, Rayala Vinay, Zubin Keki Gandhi. Its latest AGM occurred on 30 August 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No. 201, P.No. 76,, Lotus Residency, Ayyapa Society, Shaikpet, Telangana, 500081.
U24290TG2022PTC158573
158573
06 January 2022
₹1.70 Cr
₹1.70 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Orizo Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Zubin Keki Gandhi | Director | 24 May 2023 | Current |
| Yatin Kirtanlal Desai | Director | 24 May 2023 | Current |
| Punit Chunilal Thakrar | Director | 24 May 2023 | Current |
| Amol Ashok Walke | Director | 24 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Mar 2022 | Past |
| Pramod Abcsdd | Director | 25 Mar 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Orizo Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.79% increase in profit. The company's net worth dipped by a decrease of 0.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Orizo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Orizo Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Orizo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orizo Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Orizo Pharma Private Limited last Annual general meeting of members was held on 30 Aug 2025 as per latest MCA records. was recorded as a recent event.
The activity Orizo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
Zubin Keki Gandhi was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The activity Yatin Kirtanlal Desai was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 2 years 7 months . was completed.
Progress on Punit Chunilal Thakrar was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 2 years 7 months . was documented.
The activity Amol Ashok Walke was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 2 years 7 months . was completed.
The CIN of Orizo Pharma Private Limited is U24290TG2022PTC158573.
Orizo Pharma Private Limited is headquartered at Flat No. 201, P.No. 76,, Lotus Residency, Ayyapa Society, Shaikpet, Telangana, 500081.
Orizo Pharma Private Limited was incorporated on 06 January 2022.
The current directors of Orizo Pharma Private Limited are
The primary industry of Orizo Pharma Private Limited is Pharma.
Orizo Pharma Private Limited is unlisted.
The authorized capital of Orizo Pharma Private Limited is ₹1.70 Cr, and the paid-up capital is ₹1.70 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX